Advisor OS’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,006
Closed -$302K 462
2025
Q1
$302K Sell
2,006
-879
-30% -$147K 0.03% 322
2024
Q4
$533K Sell
2,885
-11,250
-80% -$2.17M 0.06% 216
2024
Q3
$2.78M Sell
14,135
-2,429
-15% -$505K 0.28% 62
2024
Q2
$3.42M Buy
16,564
+2,207
+15% +$500K 0.37% 44
2024
Q1
$3.89M Sell
14,357
-2
-0% -$478 0.45% 37
2023
Q4
$3.39M Sell
14,359
-179
-1% -$35.2K 0.44% 36
2023
Q3
$2.85M Buy
14,538
+5,794
+66% +$1.19M 0.43% 41
2023
Q2
$1.84M Buy
8,744
+4,392
+101% +$874K 0.3% 64
2023
Q1
$878K Buy
4,352
+186
+4% +$42.2K 0.21% 118
2022
Q4
$908K Buy
4,166
+931
+29% +$203K 0.24% 96
2022
Q3
$637K Sell
3,235
-609
-16% -$131K 0.19% 110
2022
Q2
$822K Buy
3,844
+298
+8% +$72.8K 0.24% 97
2022
Q1
$1M Buy
3,546
+389
+12% +$120K 0.29% 81
2021
Q4
$1.19M Buy
3,157
+347
+12% +$135K 0.24% 94
2021
Q3
$1.16M Buy
2,810
+400
+17% +$166K 0.25% 90
2021
Q2
$890K Buy
2,410
+1,003
+71% +$335K 0.18% 98
2021
Q1
$408K Buy
1,407
+578
+70% +$161K 0.09% 132
2020
Q4
$207K Buy
+829
New +$197K 0.06% 131

Other funds holding CRL